• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Surmodics accomodates Ramius with two new board members

January 6, 2011 By drugdelivery

SRDX logo

SurModics Inc. (NSDQ:SRDX) named two board members put forth by its largest shareholder, New York-based investment firm Ramius LLC.

The Eden Prairie, Minn.-based company said it named Ramius managing director Jeffrey Smith and Wheatley Partners partner Dr. David Dantzker to the board effective immediately.

Directors John Meslow and Kenneth Keller will step down from the board after Surmodics’ Feb. 7 annual meeting. Meslow has had a seat on the board since 2000, Keller since 1997, according to a press release.

It’s the latest round in an ongoing proxy fight between the companies, in which Ramius attempted to name three new directors to Surmodics’ board. Part of the agreement stipulates that Ramius will drop its campaign to place Andrea Group managing director Jeffrey Meckler on the board and committed to vote its 12 percent share of the company in favor of Smith and Dantzker.

SurModics also announced that its board formed a special committee to explore strategic alternatives for the SurModics pharmaceuticals business, which is losing money. The committee plans to work with Minneapolis investment bank Piper Jaffray & Co., which the company had already hired for the same purpose. The group will consist of board members Smith — as committee chairman — in addition to Dr. Dantzker, John Benson and Susan Knight.

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: SurModics Inc.

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS